valtrex

Generic: valacyclovir hydrochloride

Labeler: remedyrepack inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name valtrex
Generic Name valacyclovir hydrochloride
Labeler remedyrepack inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

valacyclovir hydrochloride 1 g/1

Manufacturer
REMEDYREPACK INC.

Identifiers & Regulatory

Product NDC 70518-2039
Product ID 70518-2039_499baba0-82b1-4029-e063-6294a90a0297
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020487
Listing Expiration 2027-12-31
Marketing Start 2019-04-26

Pharmacologic Class

Classes
dna polymerase inhibitors [moa] herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc] nucleoside analog [ext]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 705182039
Hyphenated Format 70518-2039

Supplemental Identifiers

RxCUI
212448 313564
UNII
G447S0T1VC

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name valtrex (source: ndc)
Generic Name valacyclovir hydrochloride (source: ndc)
Application Number NDA020487 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1 g/1
source: ndc
Packaging
  • 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2039-1)
  • 5 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2039-2)
source: ndc

Packages (2)

Ingredients (1)

valacyclovir hydrochloride (1 g/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "499baba0-82b1-4029-e063-6294a90a0297", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["212448", "313564"], "spl_set_id": ["56a62c21-bead-4f3b-a24e-c3fd0b4a732f"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2039-1)", "package_ndc": "70518-2039-1", "marketing_start_date": "20230717"}, {"sample": false, "description": "5 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2039-2)", "package_ndc": "70518-2039-2", "marketing_start_date": "20231002"}], "brand_name": "VALTREX", "product_id": "70518-2039_499baba0-82b1-4029-e063-6294a90a0297", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70518-2039", "generic_name": "valacyclovir hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VALTREX", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1 g/1"}], "application_number": "NDA020487", "marketing_category": "NDA", "marketing_start_date": "20190426", "listing_expiration_date": "20271231"}